Assessing the Efficacy of Pyrolysis–Gas Chromatography–Mass Spectrometry for Nanoplastic and Microplastic Analysis in Human Blood

Humans are constantly exposed to micro- and nanosized plastics (MNPs); however, there is still limited understanding of their fate within the body, partially due to limitations with current analytical techniques. The current study assessed the appropriateness of pyrolysis-gas chromatography-mass spectrometry (Py-GC-MS) analysis for the quantification of a range of polymers in human blood. An extraction protocol that reduced matrix interferences (false positives) of polyethylene (PE) and polyvinyl chloride (PVC) was developed and validated. Extraction recoveries ranged 7-109%, although surface-modified polystyrene (carboxylated) increased nanoparticle recoveries from 17 to 52%. Realistic detection limits were calculated for each polymer, accounting for matrix suppression and extraction recovery. These were up to 20 times higher than nominal detection limits calculated with Milli-Q water. Finally, the method was tested with a pilot study of the Australian population. PE interferences were reduced but still present, and no other polymers were above detection limits. It was concluded that Py-GC-MS is currently not a suitable analysis method for PE and PVC in biological matrices due to the presence of interferences and nonspecific pyrolysis products. Furthermore, while it is plausible to detect some polymers in blood, the estimated exposure concentrations needed are approaching the detection limits of the technique.